CD8A and ovarian carcinoma: In ovarian cancer, TLS presence, as was defined by colocalization of CD20+ B-cells with CD8+ cytotoxic T-cells, has been associated with improved survival outcome, an effect that was not replicated by CD8+ T-cell presence alone [44].